Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lupus Coagulation Inhibitor

"Lupus Coagulation Inhibitor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

An antiphospholipid antibody found in association with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; and in a variety of other diseases as well as in healthy individuals. In vitro, the antibody interferes with the conversion of prothrombin to thrombin and prolongs the partial thromboplastin time. In vivo, it exerts a procoagulant effect resulting in thrombosis mainly in the larger veins and arteries. It further causes obstetrical complications, including fetal death and spontaneous abortion, as well as a variety of hematologic and neurologic complications.


This graph shows the total number of publications written about "Lupus Coagulation Inhibitor" by people in Harvard Catalyst Profiles by year, and whether "Lupus Coagulation Inhibitor" was a major or minor topic of these publication.
Bar chart showing 13 publications over 10 distinct years, with a maximum of 2 publications in 2014 and 2016 and 2021
To see the data from this visualization as text, click here.
Related Networks
People
Explore
_
Similar Concepts
_
Top Journals 
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.